No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| LFSTLifeStance Health Group, Inc. | 2.89B | 7.44 | -49.60 | 18.5% | -0.67% | -0.61% | 2.96% | 0.34 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 212.52M | 377.22M | 667.51M | 859.54M | 1.06B | 1.25B |
| Revenue Growth % | - | 0.77% | 0.77% | 0.29% | 0.23% | 0.19% |
| Cost of Goods Sold | 150.12M | 242.9M | 466M | 622.52M | 753.57M | 848.57M |
| COGS % of Revenue | 0.71% | 0.64% | 0.7% | 0.72% | 0.71% | 0.68% |
| Gross Profit | 62.4M | 134.32M | 201.51M | 237.02M | 302.1M | 402.4M |
| Gross Margin % | 0.29% | 0.36% | 0.3% | 0.28% | 0.29% | 0.32% |
| Gross Profit Growth % | - | 1.15% | 0.5% | 0.18% | 0.27% | 0.33% |
| Operating Expenses | 47.16M | 118.88M | 487.86M | 447.19M | 491.23M | 434.01M |
| OpEx % of Revenue | 0.22% | 0.32% | 0.73% | 0.52% | 0.47% | 0.35% |
| Selling, General & Admin | 41.06M | 87.84M | 433.73M | 377.99M | 410.79M | 363.06M |
| SG&A % of Revenue | 0.19% | 0.23% | 0.65% | 0.44% | 0.39% | 0.29% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - |
| Other Operating Expenses | 6.09M | 31.05M | 54.14M | 69.2M | 80.44M | 70.95M |
| Operating Income | 15.24M | 15.44M | -286.35M | -210.17M | -189.13M | -31.61M |
| Operating Margin % | 0.07% | 0.04% | -0.43% | -0.24% | -0.18% | -0.03% |
| Operating Income Growth % | - | 0.01% | -19.55% | 0.27% | 0.1% | 0.83% |
| EBITDA | 21.34M | 46.48M | -232.22M | -140.98M | -108.7M | 39.34M |
| EBITDA Margin % | 0.1% | 0.12% | -0.35% | -0.16% | -0.1% | 0.03% |
| EBITDA Growth % | - | 1.18% | -6% | 0.39% | 0.23% | 1.36% |
| D&A (Non-Cash Add-back) | 6.09M | 31.05M | 54.14M | 69.2M | 80.44M | 70.95M |
| EBIT | 15.24M | -22.28M | -294.19M | -212.8M | -185.36M | -31.08M |
| Net Interest Income | -5.41M | 0 | -38.91M | -19.93M | -21.22M | -26.54M |
| Interest Income | 0 | 22.13M | 0 | 0 | 0 | 0 |
| Interest Expense | 5.41M | 22.13M | 38.91M | 19.93M | 21.22M | 26.54M |
| Other Income/Expense | -7.37M | -59.85M | -46.75M | -22.56M | -17.45M | -26M |
| Pretax Income | 7.88M | -44.41M | -333.11M | -232.73M | -206.58M | -57.61M |
| Pretax Margin % | 0.04% | -0.12% | -0.5% | -0.27% | -0.2% | -0.05% |
| Income Tax | 2.21M | -6.34M | -25.91M | -17.17M | -20.32M | -170K |
| Effective Tax Rate % | 0.72% | 0.86% | 0.92% | 0.93% | 0.9% | 1% |
| Net Income | 5.67M | -38.07M | -307.2M | -215.56M | -186.26M | -57.44M |
| Net Margin % | 0.03% | -0.1% | -0.46% | -0.25% | -0.18% | -0.05% |
| Net Income Growth % | - | -7.72% | -7.07% | 0.3% | 0.14% | 0.69% |
| Net Income (Continuing) | 5.67M | -38.07M | -307.2M | -215.56M | -186.26M | -57.44M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.02 | -0.83 | -1.05 | -0.61 | -0.51 | -0.15 |
| EPS Growth % | - | -55.61% | -0.27% | 0.42% | 0.16% | 0.71% |
| EPS (Basic) | 0.02 | -0.83 | -1.05 | -0.61 | -0.51 | -0.15 |
| Diluted Shares Outstanding | 373.65M | 373.65M | 327.52M | 355.28M | 367.46M | 379.15M |
| Basic Shares Outstanding | 373.65M | 373.65M | 327.52M | 355.28M | 367.46M | 379.15M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 27.43M | 76.28M | 266.52M | 233.22M | 225.73M | 312.51M |
| Cash & Short-Term Investments | 3.48M | 18.83M | 148.03M | 108.62M | 78.82M | 154.57M |
| Cash Only | 3.48M | 18.83M | 148.03M | 108.62M | 78.82M | 154.57M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 19.13M | 43.71M | 99.31M | 101.51M | 125.64M | 132.03M |
| Days Sales Outstanding | 32.86 | 42.29 | 54.3 | 43.1 | 43.44 | 38.52 |
| Inventory | 0 | 0 | 38.07M | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | 29.82 | - | - | - |
| Other Current Assets | 0 | 7.81M | -25.72M | 11M | 10.73M | 14.9M |
| Total Non-Current Assets | 253.35M | 1.49B | 1.66B | 1.94B | 1.88B | 1.81B |
| Property, Plant & Equipment | 22.43M | 59.35M | 152.24M | 393.62M | 358.93M | 313.92M |
| Fixed Asset Turnover | 9.48x | 6.36x | 4.38x | 2.18x | 2.94x | 3.99x |
| Goodwill | 214.61M | 1.1B | 1.2B | 1.27B | 1.29B | 1.29B |
| Intangible Assets | 14.95M | 332.8M | 300.36M | 263.29M | 221.07M | 190.8M |
| Long-Term Investments | 0 | -10.85M | -42.56M | 0 | 0 | 0 |
| Other Non-Current Assets | 1.36M | 2.65M | 3.45M | 10.79M | 10.89M | 7.72M |
| Total Assets | 280.78M | 1.57B | 1.93B | 2.17B | 2.11B | 2.12B |
| Asset Turnover | 0.76x | 0.24x | 0.35x | 0.40x | 0.50x | 0.59x |
| Asset Growth % | - | 4.59% | 0.23% | 0.13% | -0.03% | 0% |
| Total Current Liabilities | 55.01M | 75.92M | 116.75M | 176M | 202.87M | 228.89M |
| Accounts Payable | 8.3M | 7.69M | 14.15M | 24.37M | 23.21M | 7.24M |
| Days Payables Outstanding | 20.17 | 11.55 | 11.08 | 14.29 | 11.24 | 3.12 |
| Short-Term Debt | 0 | 3.74M | 1.32M | 2.35M | 2.92M | 7.25M |
| Deferred Revenue (Current) | 0 | 0 | 1000K | 0 | 0 | 0 |
| Other Current Liabilities | 23.17M | 19.25M | -50.83M | 16.47M | 8.93M | 18.98M |
| Current Ratio | 0.50x | 1.00x | 2.28x | 1.33x | 1.11x | 1.37x |
| Quick Ratio | 0.50x | 1.00x | 1.96x | 1.33x | 1.11x | 1.37x |
| Cash Conversion Cycle | - | - | 73.04 | - | - | - |
| Total Non-Current Liabilities | 392.13M | 495.97M | 265.33M | 479.15M | 478.17M | 443.13M |
| Long-Term Debt | 79.31M | 362.53M | 157.42M | 225.08M | 280.29M | 279.79M |
| Capital Lease Obligations | 0 | 0 | 0 | 212.59M | 181.36M | 148.7M |
| Deferred Tax Liabilities | 863K | 81.23M | 54.28M | 38.7M | 15.57M | 14.33M |
| Other Non-Current Liabilities | 311.95M | 17.21M | 53.63M | 2.78M | 952K | 309K |
| Total Liabilities | 447.13M | 571.89M | 382.08M | 655.15M | 681.04M | 672.01M |
| Total Debt | 79.31M | 366.27M | 158.74M | 478.83M | 511.04M | 485.19M |
| Net Debt | 75.83M | 347.44M | 10.71M | 370.21M | 432.22M | 330.62M |
| Debt / Equity | - | 0.37x | 0.10x | 0.32x | 0.36x | 0.34x |
| Debt / EBITDA | 3.72x | 7.88x | - | - | - | 12.33x |
| Net Debt / EBITDA | 3.55x | 7.47x | - | - | - | 8.40x |
| Interest Coverage | 2.82x | 0.70x | -7.36x | -10.55x | -8.91x | -1.19x |
| Total Equity | -166.35M | 997.84M | 1.55B | 1.52B | 1.43B | 1.45B |
| Equity Growth % | - | 7% | 0.55% | -0.02% | -0.06% | 0.01% |
| Book Value per Share | -0.45 | 2.67 | 4.72 | 4.27 | 3.89 | 3.81 |
| Total Shareholders' Equity | -166.35M | 997.84M | 1.55B | 1.52B | 1.43B | 1.45B |
| Common Stock | 3K | 1.01B | 3.74M | 3.76M | 3.79M | 3.83M |
| Retained Earnings | -166.36M | -13.13M | -357.07M | -572.64M | -760.85M | -818.29M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | -35M | 0 | 3.27M | 2.3M | 929K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 17.05M | -8.53M | 9.42M | 52.79M | -16.88M | 107.26M |
| Operating CF Margin % | 0.08% | -0.02% | 0.01% | 0.06% | -0.02% | 0.09% |
| Operating CF Growth % | - | -1.5% | 2.1% | 4.6% | -1.32% | 7.35% |
| Net Income | 5.67M | -38.07M | -307.2M | -215.56M | -186.26M | -57.44M |
| Depreciation & Amortization | 6.09M | 31.05M | 54.14M | 69.2M | 80.44M | 70.95M |
| Stock-Based Compensation | 54K | 1.45M | 259.44M | 187.43M | 99.39M | 76.17M |
| Deferred Taxes | 1.76M | 0 | -26.95M | -16.73M | -21.92M | -958K |
| Other Non-Cash Items | 478K | -2.21M | 27.85M | 45.4M | 45.2M | 45.91M |
| Working Capital Changes | 2.99M | -753K | 2.14M | -16.94M | -33.72M | -27.37M |
| Change in Receivables | -5.76M | -13.3M | -24.21M | -21.66M | -24.18M | -6.4M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.54M | 829K | 623K | 7.67M | -5.61M | 501K |
| Cash from Investing | -73.38M | -861.17M | -194.08M | -139.46M | -60.34M | -21.57M |
| Capital Expenditures | -14.31M | -38.07M | -94.49M | -79.25M | -40.52M | -21.57M |
| CapEx % of Revenue | 0.07% | 0.1% | 0.14% | 0.09% | 0.04% | 0.02% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 48.46M | 912.27M | 313.86M | 47.26M | 47.43M | -9.95M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | -6.99M | 600.87M | -12.28M | -21.39M | -7.86M | -8.26M |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | 2.73M | -46.6M | -85.07M | -26.47M | -57.4M | 85.69M |
| FCF Margin % | 0.01% | -0.12% | -0.13% | -0.03% | -0.05% | 0.07% |
| FCF Growth % | - | -18.04% | -0.83% | 0.69% | -1.17% | 2.49% |
| FCF per Share | 0.01 | -0.12 | -0.26 | -0.07 | -0.16 | 0.23 |
| FCF Conversion (FCF/Net Income) | 3.01x | 0.22x | -0.03x | -0.24x | 0.09x | -1.87x |
| Interest Paid | 4.58M | 0 | 22.41M | 14.37M | 21.04M | 24.99M |
| Taxes Paid | 254K | 0 | 1.09M | 2.24M | 80K | 57K |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -9.16% | -24.16% | -14.07% | -12.64% | -4% |
| Return on Invested Capital (ROIC) | - | 1.85% | -14.81% | -9.15% | -7.57% | -1.3% |
| Gross Margin | 29.36% | 35.61% | 30.19% | 27.57% | 28.62% | 32.17% |
| Net Margin | 2.67% | -10.09% | -46.02% | -25.08% | -17.64% | -4.59% |
| Debt / Equity | - | 0.37x | 0.10x | 0.32x | 0.36x | 0.34x |
| Interest Coverage | 2.82x | 0.70x | -7.36x | -10.55x | -8.91x | -1.19x |
| FCF Conversion | 3.01x | 0.22x | -0.03x | -0.24x | 0.09x | -1.87x |
| Revenue Growth | - | 77.5% | 76.96% | 28.77% | 22.82% | 18.5% |
LifeStance Health Group, Inc. (LFST) reported $1.37B in revenue for fiscal year 2024. This represents a 544% increase from $212.5M in 2019.
LifeStance Health Group, Inc. (LFST) grew revenue by 18.5% over the past year. This is strong growth.
LifeStance Health Group, Inc. (LFST) reported a net loss of $9.1M for fiscal year 2024.
LifeStance Health Group, Inc. (LFST) has a return on equity (ROE) of -4.0%. Negative ROE indicates the company is unprofitable.
LifeStance Health Group, Inc. (LFST) generated $119.4M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.